Replies to post #891 on Nymox Pharmaceutical Corp (NYMXF)

[MinnieM]

I'll look to see how that compares to current SOC. In the meantime, do you know why they state the primary endpoints of the trial haven't been met?

I'll check back later for the answer... no hurry since I'm about to be off the computer.

**********

Edit to add.... I see all of your edits to the last post...thanks... I'll read the links later. Creative way to beat post limit. ;)

http://streetregister.com/2016/08/27/nymox-pharmaceutical-corporation-nasdaqnymx-ignore-the-shorts/

I'm out of posts for the day,it blows SOC out of the water,shorts are spinnning the data!

https://prostatecancernewstoday.com/2016/06/23/Fexapotide-reduces-prostate-cancer-bph-men

http://www.empr.com/drugs-in-the-pipeline/fexapotide-vs-conventional-bph-treatments-evaluated-in-crossover-study/article/518832/?webSyncID=a8dacc5e-197e-11a6-5eb8-8d7c8b1c05a5&sessionGUID=be9303b7-5ba3-ba92-0443-ace3cadc1b20







In Reply to '2014turnaround'
Did you read the latest release long term benefit? 85%-92% not requiring surgery?